CTOs on the Move

The Mighty

www.themighty.com

 
The Mighty is a digital health community created to empower and connect people facing health challenges and disabilities. We have over 2.5 million registered users and are adding a new one every 20 seconds. Our stories and videos are viewed and shared more than 90 million times a month. But those are just stats. This experience from a community member is what we`re really after: “How is it that I read an essay on The Mighty and it is the only place in the world where I feel truly understood? Time and time again you speak to me through your ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.themighty.com
  • 210 N Glenoaks Boulevard Suite C
    Burbank, CA USA 91502
  • Phone: 213.379.2407

Executives

Name Title Contact Details
Peter Wang
Chief Technology Officer Profile

Similar Companies

Magellan Health

At Magellan Health, we have a unique vision of better and more affordable care in the fast growing, highly complex and high cost areas of health care. Our complete-person perspective helps us deliver better outcomes and brighter futures. Magellan Health, Inc. is a health care management company headquartered in Scottsdale, AZ. The depth and breadth of our experience in managing behavioral health care, diagnostic imaging, specialty pharmaceutical services and in providing pharmacy benefits administration enable us to deliver inspired insights and innovative solutions that positively impact both the quality and the cost of some of the nation`s fastest growing areas of health care. Magellan is proud to be a founding member of Hero Health Hire, a coalition of health care companies committed to recruiting, hiring and training veterans, wounded warriors and military spouses.

Acuity Medical Systems

Acuity Medical Systems is a Wayzata, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioMS Medical Corporation

BioMS Medical Corporation is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.